Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study | Zendy

Marisa Montes | Zendy; Mark Nelson | Zendy; PierreMarie Girard | Zendy; Joe Sasadeusz | Zendy; Andrzej Horban | Zendy; Beatriz Grinsztejn | Zendy; Natalia Zakharova | Zendy; Antonio Rivero | Zendy; J. Durant | Zendy; E Ortega-González | Zendy; Erkki Lathouwers | Zendy; Katrien Janssen | Zendy; Sivi OuwerkerkMahadevan | Zendy; James Witek | Zendy; Juan GonzálezGarcía | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study

Author(s) -

Marisa Montes,

Mark Nelson,

PierreMarie Girard,

Joe Sasadeusz,

Andrzej Horban,

Beatriz Grinsztejn,

Natalia Zakharova,

Antonio Rivero,

J. Durant,

E Ortega-González,

Erkki Lathouwers,

Katrien Janssen,

Sivi OuwerkerkMahadevan,

James Witek,

Juan GonzálezGarcía

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv323

Subject(s) - telaprevir , medicine , efavirenz , ribavirin , raltegravir , gastroenterology , ritonavir , rash , adverse effect , darunavir , pegylated interferon , hepatitis c , hepatitis c virus , virology , viral load , human immunodeficiency virus (hiv) , virus , antiretroviral therapy

INSIGHT (ClinicalTrials.gov NCT01513941) evaluated the efficacy, safety and pharmacokinetics of telaprevir-based therapy and specific antiretroviral agents in hepatitis C virus genotype 1 (HCV-1)/HIV-1-coinfected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research